These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9028955)

  • 1. Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction.
    Kalai M; Montero-Julian FA; Grötzinger J; Fontaine V; Vandenbussche P; Deschuyteneer R; Wollmer A; Brailly H; Content J
    Blood; 1997 Feb; 89(4):1319-33. PubMed ID: 9028955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface.
    Salvati AL; Lahm A; Paonessa G; Ciliberto G; Toniatti C
    J Biol Chem; 1995 May; 270(20):12242-9. PubMed ID: 7744875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex.
    Horsten U; Müller-Newen G; Gerhartz C; Wollmer A; Wijdenes J; Heinrich PC; Grötzinger J
    J Biol Chem; 1997 Sep; 272(38):23748-57. PubMed ID: 9295319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of single amino acid residues of human IL-6 involved in receptor binding and signal initiation.
    Ehlers M; Grötzinger J; Fischer M; Bos HK; Brakenhoff JP; Rose-John S
    J Interferon Cytokine Res; 1996 Aug; 16(8):569-76. PubMed ID: 8877726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.
    Savino R; Lahm A; Salvati AL; Ciapponi L; Sporeno E; Altamura S; Paonessa G; Toniatti C; Ciliberto G
    EMBO J; 1994 Mar; 13(6):1357-67. PubMed ID: 7511100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.
    Aoki Y; Narazaki M; Kishimoto T; Tosato G
    Blood; 2001 Nov; 98(10):3042-9. PubMed ID: 11698289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.
    Li H; Nicholas J
    J Virol; 2002 Jun; 76(11):5627-36. PubMed ID: 11991991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling.
    Paonessa G; Graziani R; De Serio A; Savino R; Ciapponi L; Lahm A; Salvati AL; Toniatti C; Ciliberto G
    EMBO J; 1995 May; 14(9):1942-51. PubMed ID: 7744001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor.
    Kalai M; Montero-Julian FA; Grötzinger J; Wollmer A; Morelle D; Brochier J; Rose-John S; Heinrich PC; Brailly H; Content J
    Eur J Biochem; 1996 Jun; 238(3):714-23. PubMed ID: 8706672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
    Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
    EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular design of human IL-6 receptor antagonists.
    Lahm A; Savino R; Salvati AL; Cabibbo A; Ciapponi L; Demartis A; Toniatti C; Paonessa G; Altamura S; Ciliberto G
    Ann N Y Acad Sci; 1995 Jul; 762():136-50; discussion 150-1. PubMed ID: 7668525
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.
    Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ
    Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of immobilized synthetic peptides for the identification of contact sites between human interleukin-6 and its receptor.
    Weiergräber O; Schneider-Mergener J; Grötzinger J; Wollmer A; Küster A; Exner M; Heinrich PC
    FEBS Lett; 1996 Jan; 379(2):122-6. PubMed ID: 8635575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics analysis of the binding of human interleukin-6 with interleukin-6 α-receptor.
    Gupta M; Ha K; Agarwal R; Quarles LD; Smith JC
    Proteins; 2021 Feb; 89(2):163-173. PubMed ID: 32881084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a soluble IL-6 receptor alpha mutant C277D/H280I expressed in E.coli.
    Duan J; Wang J; Cai X; Wang L; Liu H; Zou M
    Biochem Mol Biol Int; 1997 May; 41(6):1101-8. PubMed ID: 9161704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.
    Hammond ME; Shyamala V; Siani MA; Gallegos CA; Feucht PH; Abbott J; Lapointe GR; Moghadam M; Khoja H; Zakel J; Tekamp-Olson P
    J Biol Chem; 1996 Apr; 271(14):8228-35. PubMed ID: 8626516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6.
    Boulanger MJ; Chow DC; Brevnova E; Martick M; Sandford G; Nicholas J; Garcia KC
    J Mol Biol; 2004 Jan; 335(2):641-54. PubMed ID: 14672670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
    Ward LD; Hammacher A; Howlett GJ; Matthews JM; Fabri L; Moritz RL; Nice EC; Weinstock J; Simpson RJ
    J Biol Chem; 1996 Aug; 271(33):20138-44. PubMed ID: 8702737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.
    Sporeno E; Savino R; Ciapponi L; Paonessa G; Cabibbo A; Lahm A; Pulkki K; Sun RX; Toniatti C; Klein B; Ciliberto G
    Blood; 1996 Jun; 87(11):4510-9. PubMed ID: 8639818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.